Companies / ImmunityBio, Inc.

ImmunityBio, Inc.

Nasdaq: IBRXCIK 1326110SAN DIEGO, CA

Financials · FY2025

Revenue$113.29M
Net income$-351.47M
Total debt$884.0K
Cash$75.67M
Diluted EPS$-0.38
Shares outstanding1.06B

Ownership

1.06B shares outstanding · as of Jul 31, 2026
26.8%Insiders
Ownership
Insiders26.85%284,555,934
Institutions18.89%200,253,147
Public float54.26%575,027,192

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 15

View all →
Insider% of sharesShares
Soon-Shiong PatrickSee remarks · Director · 10% owner
26.49%280,776,784
0.26%2,802,788
Adcock RichardCEOCEO & President · Director
0.05%560,344
Sachs David C.Chief Financial Officer
0.03%300,143
Lauer Regan JChief Accounting Officer
0.01%115,875
0.00%0
Clark WesleyDirector

Institutional holders 292

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 31, 2026Soon-Shiong Patrick
Executive
OtherCommon Stock$25.00M+4.6M
+1.87%
251,018,873
23.68% of shares
low
Feb 23, 2026Simon Barry J.
Director
SellCommon Stock$1.69M-165K
-5.34%
2,925,821
0.28% of shares
medium
Feb 10, 2026Adcock Richard
CEO
OtherCommon Stock$970.5K-140K
-22.39%
485,465
0.05% of shares
low
Feb 24, 2026Simon Barry J.
Director
SellCommon Stock$900.8K-75K
-2.56%
2,850,821
0.27% of shares
medium
Feb 10, 2026Soon-Shiong Patrick
Executive
OtherCommon Stock$821.6K-119K
-0.40%
29,701,752
2.80% of shares
low
Feb 22, 2026Adcock Richard
CEO
OtherCommon Stock$674.8K-78K
-12.16%
560,344
0.05% of shares
low
Jan 20, 2026Simon Barry J.
Director
SellCommon Stock$590.9K-75K
-2.37%
3,091,604
0.29% of shares
medium
Feb 22, 2026Soon-Shiong Patrick
Executive
OtherCommon Stock$506.1K-58K
-0.20%
29,757,911
2.81% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IBRXCommon StockEquity45256X103BBG007T9DYW9